Turkey tail Trametes versicolor (L.) Lloyd
Also called: Coriolus versicolor, yun zhi, kawaratake, polysaccharide-K (PSK), polysaccharopeptide (PSP)
Turkey tail, Trametes versicolor, is a woody bracket fungus that grows on dead logs worldwide. Hot-water extracts of its cultivated mycelium include PSK, approved in Japan as an add-on cancer treatment, and PSP from China; other extracts are sold as supplements.
- Category
- Mushroom
- Forms
- Cultivated mycelium (hot-water extracts such as PSK and PSP)
- Strongest evidence
- B Some positive trials
- Reviewed
- 2026-10-28
Class 1 Well studied in people. A 2022 Cochrane review included 7 RCTs (1,569 people with colorectal cancer) of Coriolus versicolor extracts (described as PSK, polysaccharide-Krestin) added to chemotherapy versus chemotherapy alone, pooling up to 5 trials per outcome. [2]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Survival after surgery for gastric cancer (PSK with chemotherapy) | B | 2007 meta-analysis of 8 RCTs (8,009 patients): adding PSK to chemotherapy after curative surgery was linked to longer overall survival (HR 0.88, 95% CI 0.79–0.98). [1] |
| Side effects of treatment and survival in colorectal cancer | C | Cochrane 2022: 7 RCTs (1,569 participants), 6 in Japan. Low-certainty evidence of a small 5-year survival benefit (RR 1.08); very low certainty on side effects. Chemotherapy regimens do not reflect current practice. [2] |
| Lung cancer (PSK with standard treatment) | C | A systematic review found 6 RCTs using PSK 3 g/day with chemotherapy; each reported benefit on at least one endpoint (immune measures, weight, performance status, symptoms or survival). [1] |
| Immune measures in breast cancer | C | Studies in breast cancer have measured changes in blood immune cells, not clinical outcomes such as survival, symptoms or quality of life. [1] |
Main constituents: PSK: a protein-bound beta-glucan mixture averaging 9.4 kDa (range 5–300 kDa); 25% to 38% of its mass is covalently linked protein [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- PSK 3 g/day was the dose in most gastric and lung cancer trials. [1]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingMSK: until safety data become available, pregnant or breastfeeding women should avoid taking Coriolus; it is not known if this mushroom is safe.
1 statement in the profile.
Details and sources - Interactions with medicines2 listed
Medicines in general; Tamoxifen (rat study)
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications5 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- PSK has been used as an adjunctive cancer treatment in thousands of patients in Japan since the mid-1970s, with few adverse events reported. [1]
- Rare effects: dark stools not caused by bleeding, darkening of fingernails, and low-grade blood and digestive toxicities when combined with chemotherapy (possibly due to the chemotherapy). [3]
- Pregnancy and breastfeeding: MSK advises avoiding turkey tail until safety data become available. [3]
Identity, quality and standardization
- Many over-the-counter products are not standardized, and it is unclear whether PSK, PSP and other extracts have comparable effects. [3]
- Other Trametes species are difficult to distinguish from turkey tail; ITS DNA sequences alone are inadequate for identification. [1]
- Index Fungorum lists Coriolus versicolor as a synonym of Trametes versicolor. [4]
Regulatory status
- Japan: PSK, a proprietary T. versicolor product, is an approved mushroom product used for cancer treatment. [1]
- US: PSP and other Coriolus extracts are available as dietary supplements. [3]
- US: medicinal mushrooms are sold as dietary supplements, which do not require FDA premarket evaluation and approval. The FDA has not approved medicinal mushrooms as a treatment for cancer or any other medical condition. [1]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- PSK (polysaccharide-K): a protein-bound beta-glucan mixture, average 9.4 kDa (range 5–300 kDa), main chain beta-(1,4) glucan with beta-(1,3) and beta-(1,6) side chains, 25% to 38% covalently linked protein, plus small amounts of galactose, mannose and arabinose Protein-bound polysaccharide (beta-glucan) [P1]
- PSP (polysaccharopeptide), purified from a different turkey tail strain Protein-bound polysaccharide [P1]
- Lipid component, mainly linoleic acid, with toll-like receptor 2 agonist activity acting synergistically with the protein-bound beta-glucan Fatty acids [P1]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 5 entries naming turkey tail (Trametes or Coriolus versicolor, or yun zhi) (earliest NDI 63 submitted 1997-01-07; most recent NDI 792 submitted 2013-03-22). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P2]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- Medicines in general: MSK: Coriolus extracts can interact with some medications and affect how they work (no specific drugs named). [P5]
- Tamoxifen (rat study): In rats, a PSP extract increased tamoxifen Tmax by 228% after a single dose and 93% with repeated dosing, without significant change in AUC or Cmax; human data are not reported. [P6]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination of each component that is a dietary ingredient — Required by 21 CFR 111.75(a)(1)(i) for every dietary-ingredient component; an exemption may be requested by petition under 21 CFR 10.30. [P7]
- Species identity confirmation (ITS sequencing alone is not sufficient) — Internal transcribed spacer (ITS) sequences alone have been found inadequate to distinguish turkey tail from other Trametes species. [P1]
Supply and conservation
- PSK is a purified hot-water extract prepared from the cultivated fungal mycelium (used in Japan); PSP is a T. versicolor extract produced in China. [P1]
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- MSK: until safety data become available, pregnant or breastfeeding women should avoid taking Coriolus; it is not known if this mushroom is safe. [P5]
Sources for this profile
- National Cancer Institute. Medicinal Mushrooms (PDQ®)–Health Professional Version (latest update 11/06/2024), 2024-11-06. cancer.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. Agents Classified by the IARC Monographs: List of Classifications (accessed 2026-10-29), 2026-10-29. monographs.iarc.who.int
- National Toxicology Program (NIEHS). Technical Reports list (accessed 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Coriolus Versicolor (last updated April 22, 2026), 2026-04-22. mskcc.org
- Razmovski-Naumovski V, et al. Polysaccharide Peptide Extract From Coriolus versicolor Increased Tmax of Tamoxifen ... in the Rat. Front Pharmacol 2022;13:857864 (PMID 35450034), 2022-04-01. pubmed.ncbi.nlm.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
Sources
- National Cancer Institute. Medicinal Mushrooms (PDQ®)–Health Professional Version (latest update 11/06/2024), 2024-11-06. cancer.gov
- Pilkington K, et al. Coriolus (Trametes) versicolor mushroom to reduce adverse effects from chemotherapy or radiotherapy in people with colorectal cancer. Cochrane Database Syst Rev 2022;11:CD012053, 2022-11-29. pubmed.ncbi.nlm.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Coriolus Versicolor (last updated April 22, 2026), 2026-04-22. mskcc.org
- Index Fungorum. Coriolus versicolor (L.) Quél., record 121643 (accessed October 28, 2026). indexfungorum.org
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in mushroom: Chaga · Cordyceps · Lion's mane · Maitake · Reishi · Shiitake · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.